FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2050484141> ?p ?o ?g. }

• W2050484141 endingPage "59" @default.
• W2050484141 startingPage "49" @default.
• W2050484141 abstract "The histamine (H2)-receptor antagonist famotidine was compared with ranitidine and cimetidine in its ability to control gastric acid hypersecretion in 33 patients with gastric hypersecretory states (32 patients with Zollinger-Ellison syndrome and one patient with idiopathic hypersecretion). Equipotent doses of each drug were determined in nine patients and used to determine relative onset of action, duration of action, and potency. Each drug had a similar time course of onset with a maximal effect at three to four hours after oral ingestion. The duration of action of famotidine was 30 percent longer than that of either cimetidine or ranitidine. In terms of relative potency, famotidine was nine times more potent than ranitidine and 32 times more potent than cimetidine. Thirty-two patients underwent long-term famotidine treatment for up to 34 months (mean, 10 months) with a duration in 21 patients of at least six months, in nine patients of at least 12 months, and in six patients of at least 24 months. The mean daily maintenance dose with famotidine was 0.33 g per day (range, 0.05 to 0.8 g). Prior to famotidine therapy, 27 patients were taking ranitidine and the mean daily dose required was 2.3 g per day (range, 0.6 to 5.4 g), whereas six patients were taking cimetidine and the mean daily dose was 4.6 g per day (range, 1.2 to 9.0 g). Fourteen of the 32 patients required an anticholinergic agent in addition to ranitidine or cimetidine to maintain control, whereas only five patients required an anticholinergic agent with famotidine. Gastric acid hypersecretion was controlled in seven patients with less frequent dosing with famotidine than with cimetidine or ranitidine. Long-term treatment with famotidine was not associated with any hematologic or biochemical toxicity or clinical side effects. These results demonstrate that famotidine has a similar onset of action to other H2-receptor antagonists but has a 30 percent longer duration of action and is nine times more potent than ranitidine and 32 times more potent than cimetidine. Famotidine is safe and highly effective in the long-term treatment of gastric hypersecretory states." @default.
• W2050484141 created "2016-06-24" @default.
• W2050484141 creator A5005161415 @default.
• W2050484141 creator A5010478795 @default.
• W2050484141 creator A5031916299 @default.
• W2050484141 creator A5039732159 @default.
• W2050484141 creator A5042446268 @default.
• W2050484141 creator A5089678785 @default.
• W2050484141 creator A5090479221 @default.
• W2050484141 date "1986-10-01" @default.
• W2050484141 modified "2023-10-03" @default.
• W2050484141 title "Famotidine in the therapy of gastric hypersecretory states" @default.
• W2050484141 cites W122184333 @default.
• W2050484141 cites W1615457766 @default.
• W2050484141 cites W1923168725 @default.
• W2050484141 cites W1967535629 @default.
• W2050484141 cites W1968346218 @default.
• W2050484141 cites W1982423051 @default.
• W2050484141 cites W1995109962 @default.
• W2050484141 cites W2006701506 @default.
• W2050484141 cites W2017328004 @default.
• W2050484141 cites W2034522110 @default.
• W2050484141 cites W2057913578 @default.
• W2050484141 cites W2062318231 @default.
• W2050484141 cites W2069847921 @default.
• W2050484141 cites W2075934444 @default.
• W2050484141 cites W2088120307 @default.
• W2050484141 cites W2336037279 @default.
• W2050484141 cites W2468301999 @default.
• W2050484141 cites W4298241815 @default.
• W2050484141 doi "https://doi.org/10.1016/0002-9343(86)90600-5" @default.
• W2050484141 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2877575" @default.
• W2050484141 hasPublicationYear "1986" @default.
• W2050484141 type Work @default.
• W2050484141 sameAs 2050484141 @default.
• W2050484141 citedByCount "50" @default.
• W2050484141 countsByYear W20504841412013 @default.
• W2050484141 countsByYear W20504841412015 @default.
• W2050484141 countsByYear W20504841412022 @default.
• W2050484141 countsByYear W20504841412023 @default.
• W2050484141 crossrefType "journal-article" @default.
• W2050484141 hasAuthorship W2050484141A5005161415 @default.
• W2050484141 hasAuthorship W2050484141A5010478795 @default.
• W2050484141 hasAuthorship W2050484141A5031916299 @default.
• W2050484141 hasAuthorship W2050484141A5039732159 @default.
• W2050484141 hasAuthorship W2050484141A5042446268 @default.
• W2050484141 hasAuthorship W2050484141A5089678785 @default.
• W2050484141 hasAuthorship W2050484141A5090479221 @default.
• W2050484141 hasConcept C1122143 @default.
• W2050484141 hasConcept C126322002 @default.
• W2050484141 hasConcept C170493617 @default.
• W2050484141 hasConcept C185592680 @default.
• W2050484141 hasConcept C202751555 @default.
• W2050484141 hasConcept C2776885963 @default.
• W2050484141 hasConcept C2777445857 @default.
• W2050484141 hasConcept C2778689640 @default.
• W2050484141 hasConcept C2780719153 @default.
• W2050484141 hasConcept C2781263782 @default.
• W2050484141 hasConcept C34400551 @default.
• W2050484141 hasConcept C42219234 @default.
• W2050484141 hasConcept C55493867 @default.
• W2050484141 hasConcept C57992300 @default.
• W2050484141 hasConcept C71924100 @default.
• W2050484141 hasConcept C90924648 @default.
• W2050484141 hasConceptScore W2050484141C1122143 @default.
• W2050484141 hasConceptScore W2050484141C126322002 @default.
• W2050484141 hasConceptScore W2050484141C170493617 @default.
• W2050484141 hasConceptScore W2050484141C185592680 @default.
• W2050484141 hasConceptScore W2050484141C202751555 @default.
• W2050484141 hasConceptScore W2050484141C2776885963 @default.
• W2050484141 hasConceptScore W2050484141C2777445857 @default.
• W2050484141 hasConceptScore W2050484141C2778689640 @default.
• W2050484141 hasConceptScore W2050484141C2780719153 @default.
• W2050484141 hasConceptScore W2050484141C2781263782 @default.
• W2050484141 hasConceptScore W2050484141C34400551 @default.
• W2050484141 hasConceptScore W2050484141C42219234 @default.
• W2050484141 hasConceptScore W2050484141C55493867 @default.
• W2050484141 hasConceptScore W2050484141C57992300 @default.
• W2050484141 hasConceptScore W2050484141C71924100 @default.
• W2050484141 hasConceptScore W2050484141C90924648 @default.
• W2050484141 hasIssue "4" @default.
• W2050484141 hasLocation W20504841411 @default.
• W2050484141 hasLocation W20504841412 @default.
• W2050484141 hasOpenAccess W2050484141 @default.
• W2050484141 hasPrimaryLocation W20504841411 @default.
• W2050484141 hasRelatedWork W1923168725 @default.
• W2050484141 hasRelatedWork W2020459612 @default.
• W2050484141 hasRelatedWork W2052692376 @default.
• W2050484141 hasRelatedWork W2061267784 @default.
• W2050484141 hasRelatedWork W2137838591 @default.
• W2050484141 hasRelatedWork W2289035840 @default.
• W2050484141 hasRelatedWork W2419624814 @default.
• W2050484141 hasRelatedWork W4255419199 @default.
• W2050484141 hasRelatedWork W4290361947 @default.
• W2050484141 hasRelatedWork W1965947048 @default.
• W2050484141 hasVolume "81" @default.
• W2050484141 isParatext "false" @default.
• W2050484141 isRetracted "false" @default.

• next